Cost of medical care of type 2 diabetes mellitus outpatients - Effect of healthcare reform on the diabetes clinic

Journal of the Japan Diabetes Society

Volumn 48, Issue 9, 2005, Pages 677-684

  Inada, Oogi ^a   Nishimura, Shuzo ^a   Seino, Yutaka ^b   Tsuda, Kinsuke ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kansai Denryoku Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; INSULIN; MELBIN; METFORMIN; NATEGLINIDE; VOGLIBOSE;

AMBULATORY CARE; ARTICLE; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; COST CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INDIVIDUALIZATION; INSULIN TREATMENT; JAPAN; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 27244440125     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053
2. The Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125:177-188
3. Icks A, Rosenbauer J, Haastert B, Rathmann W, Grabert M, Gandjour A, Giani G, Holl RW (2004) Direct cost of pediatric diabetes care in Germany and their predictors. Exp Clin Endocrinol Diabetes 112: 302-309